Recently Viewed
Clear All
$610 Mln
--
10.39
39.67
0
-0.65 %
--
0 %
--
-0.83
$-214.34 Mln
$-266.00 Mln
$-265.84 Mln
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
CorMedix (CRMD)
| 29.38 | -5.76 | -7.67 | 240.26 | 38.20 | 11.14 | -4.35 |
BSE Sensex
| -2.95 | -0.51 | -2.25 | 6.13 | 9.30 | 12.87 | 10.07 |
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
---|---|---|---|---|---|---|---|
CorMedix (CRMD)
| 114.08 | -10.90 | -7.25 | -38.76 | 2.06 | 12.87 | 155.65 |
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
--
--Min --Median --Max
--
--Min --Median --Max
--
Earnings Yield (%) = EBIT / Enterprise value
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
---|---|---|---|---|
64.85 | 12,551.80 | 39.67 | 6.15 | |
63.50 | 11,522.38 | -- | -11.55 | |
72.72 | 7,349.97 | 55.67 | 23.81 | |
10.80 | 12,664.03 | -- | -4.44 |
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an... antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922 Read more
Mr. Joseph Todisco MBA
Mr. Joseph Todisco MBA
Berkeley Heights, NJ
The total asset value of CorMedix Inc (CRMD) stood at $ 96 Mln as on 30-Sep-24
The share price of CorMedix Inc (CRMD) is $10.48 (NASDAQ) as of 14-Feb-2025 16:05 EST. CorMedix Inc (CRMD) has given a return of 38.2% in the last 3 years.
CorMedix Inc (CRMD) has a market capitalisation of $ 610 Mln as on 13-Feb-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of CorMedix Inc (CRMD) is 10.39 times as on 13-Feb-2025, a 106% premium to its peers’ median range of 5.04 times.
Since, TTM earnings of CorMedix Inc (CRMD) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the CorMedix Inc (CRMD) and enter the required number of quantities and click on buy to purchase the shares of CorMedix Inc (CRMD).
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922
The CEO & director of Mr. Joseph Todisco MBA. is CorMedix Inc (CRMD), and CFO & Sr. VP is Mr. Joseph Todisco MBA.
There is no promoter pledging in CorMedix Inc (CRMD).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
1,266
|
|
1,255
|
|
1,152
|
|
735
|
CorMedix Inc. (CRMD) | Ratios |
---|---|
Return on equity(%)
|
-79.07
|
Operating margin(%)
|
-378.13
|
Net Margin(%)
|
-367.24
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of CorMedix Inc (CRMD) was $0 Mln.